Triple Negative Breast Cancer Treatment Options and Limitations: Future Outlook O Obidiro, G Battogtokh, EO Akala Pharmaceutics 15 (7), 1796, 2023 | 40 | 2023 |
Obstacles and policy measures toward COVID-19 vaccination: creating a sustainable road map for Malawi OR Kayode, OP Obidiro, US Lawrence, AB Oyetola, MM Hasan, A Olajide, ... Saudi Pharmaceutical Journal 30 (7), 1060-1063, 2022 | 6 | 2022 |
Cholera scourge in Nigeria: Promoting environmental sanitation practice to achieving good health for all OM Olaitan, TK Oluwatobi, PV Oluwaseun, OS Adaobi, MA Abiodun, ... J Infect Dis Epidemiol 8, 246, 2022 | 4 | 2022 |
Rising cholera cases: Harnessing the momentum of COVID‐19 to strengthen Nigeria's health systems RK Oladapo, AB Oyetola, OP Obidiro, A Olajide, E Osuagwu‐Nwogu, ... The International journal of health planning and management 36 (6), 2030-2034, 2021 | 4 | 2021 |
Evaluation of the effects of co-processed Manihot Esculenta starch on the tablet properties of directly compressed diclofenac and paracetamol formulations OJ Olubunmi, AN Diemuku, OP Obidiro, SO Eraga Journal of Phytomedicine and Therapeutics 23 (1), 1220–1244-1220–1244, 2024 | | 2024 |
Recent Developments in Combination Immunotherapy with Other Therapies and Nanoparticle-Based Therapy for Triple-Negative Breast Cancer (TNBC) G Battogtokh, O Obidiro, EO Akala Cancers 16 (11), 2012, 2024 | | 2024 |
Investigation of the Tableting Properties of Modified Dioscorea dumetorum Starch in Direct Compressed Diclofenac Tablet Formulations ESOIMA Obidiro OP Journal of Basic and Social Pharmacy Research 2 (3), 36-47, 2022 | | 2022 |